Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City
dc.contributor.author | Galea, Sandro | en_US |
dc.contributor.author | Worthington, Nancy | en_US |
dc.contributor.author | Piper, Tinka Markham | en_US |
dc.contributor.author | Nandi, Vijay V. | en_US |
dc.contributor.author | Curtis, Matt | en_US |
dc.contributor.author | Rosenthal, David M. | en_US |
dc.date.accessioned | 2006-07-27T18:55:31Z | |
dc.date.available | 2006-07-27T18:55:31Z | |
dc.date.issued | 2006 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/40335 | |
dc.description.abstract | Introduction: Naloxone, an opiate antagonist that can avert opiate overdose morality, has long been prescribed to drug users in Europe and in a few US cities. However, there has been little documented evidence of naloxone distribution programs and their feasibility in the peer reviewed literature in the US. Methods: A pilot overdose prevention and reversal program was implemented in a New York City syringe exchange program. We assessed demographics, drug use, and overdose history, experience, and behavior at baseline, when participants returned for prescription refills, and 3 months after baseline assessment. Results: 25 participants were recruited. 22 (88%) participants were successfully followed-up in the first 3 months; of these, 11 (50%) participants reported witnessing a total of 26 overdoses during the follow-up period. Among 17 most-recent overdoses witnessed, naloxone was administered 10 times; all persons who had naloxone administered lived. | en_US |
dc.format.extent | 1931 bytes | |
dc.format.extent | 137724 bytes | |
dc.format.mimetype | text/plain | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_US | en_US |
dc.title | Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | Epidemiology, Department of | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/40335/2/Galea_Provision of Naloxone to Injection Drug_2006.pdf | en_US |
dc.owningcollname | Epidemiology, Department of (SPH) |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.